BACKGROUND:: Previous meta-analyses reported by Gould et al found significant decreases
of 15% in the risk for coronary heart disease (CHD)-related mortality and 11 % in risk for all…

Objective Examinations of Patient‐Reported Outcomes Measurement Information System (
PROMIS ) measures in adult systemic lupus erythematosus ( SLE ) have provided support for …

Background: Few studies have been conducted in actual clinical practice settings to evaluate
the ways in which dyslipidemia is managed using lipid-modifying therapies. Objective: To …

Background: Patients with rheumatoid arthritis (RA) are at increased risk for infection after
arthroplasty, yet risks of specific biologic medications are unknown. Objective: To compare risk …

Objective. Assess whether baseline anticyclic citrullinated peptide antibodies (anti-CCP)
status is associated with treatment response in patients with rheumatoid arthritis (RA) initiating …

Objective: To evaluate prescribing patterns of lipid-lowering drugs used in management of
patients at risk of coronary heart disease (CHD) in usual clinical practice in Spain and to …

The objectives of this analysis were to assess the prevalence of Sjögren’s syndrome (SS)
associated with rheumatoid arthritis (RA) and to compare baseline characteristics of patients …

Background Treatment persistence is an important consideration when selecting a therapy
for chronic conditions such as rheumatoid arthritis (RA). We assessed the long-term …

Objective. To examine the associations between lowering low-density lipoprotein cholesterol
(LDL-C) and cardiovascular (CV) outcomes among patients with rheumatoid arthritis (RA) …

Objective To evaluate associations between achieving guideline‐recommended targets of
disease activity, defined by the Disease Activity Score in 28 joints using C‐reactive protein …